FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 5037-5044

  Chiba, Kenji ^a,b   Yanagawa, Yoshiki ^a   Masubuchi, Yumi ^a   Kataoka, Hirotoshi ^a   Kawaguchi, Takafumi ^a   Ohtsuki, Makio ^a   Hoshino, Yukio ^a  

^a Research Laboratories   (Japan)

^b Research Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CYCLODEXTRIN; CALCEIN; CYCLOSPORIN A; DRUG VEHICLE; FINGOLIMOD; HOMING RECEPTOR; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MANNITOL; MITOMYCIN C; OLIVE OIL; PADGEM PROTEIN; RECOMBINANT INTERLEUKIN 2; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE HOMING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL; RAT; SKIN ALLOGRAFT; SPLEEN LYMPHOCYTE; THORACIC DUCT;

ANIMALS; ANTIGENS, CD11; CELL LINE; CELL MOVEMENT; CYCLOSPORINE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; PROPYLENE GLYCOLS; RATS; RATS, INBRED F344; SKIN TRANSPLANTATION; SPHINGOSINE; TACROLIMUS;

EID: 0032525049     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Calne, R. Y., D. J. G. White, S. Thiru, D. B. Evans, P. McMaster, D. C. Dunn, G. N. Craddock, B. D. Pentlow, and K. Rolles. 1978. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323.
2. Starzl, T. E., R. Weil, III, S. Iwatsuki, 1980. The use of cyclosporin A and prednisolone in cadaver kidney transplantation. Surg. Gynecol. Obstet. 151:17.
3. European FK506 Multicentre Liver Study Group. 1994. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 344:423.
4. Borel, J. F. 1989. Pharmacology of cyclosporine (Sandimmune). IV. Pharmacological properties in vivo. Pharmacol. Rev. 41:283.
5. Kino, T., H. Hatanaka, S. Miyata, N. Inamura, M. Nishiyama, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and T. Ochiai. 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. 40:1256.
6. Liu, J., J. D. Farmer, Jr., W. S. Lane, J. Friedman, I. Weissman, and S. L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807.
7. Slapak, M., T. Geoghegan, N. Digard, K. Ahmed, V. L. Sharman, and R. Crockett. 1985. The use of low-dose cyclosporine in combination with azathioprine and steroids in renal transplantation. Transplant. Proc. 19:1222.
8. Kokado, Y., M. Ishibashi, H. Jiang, S. Takahara, and T. Sonoda. 1990. Low-dose cyclosporin, mizoribine, and prednisolone in renal transplantation: a new triple-drug therapy. Clin. Transplant. 4:191.
9. Fujita, T., K. Inoue, S. Yamamoto, T. Ikumoto, S. Sasaki, R. Toyama, K. Chiba, Y. Hoshino, and T. Okumoto. 1994. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J. Antibiot. 47:208.
10. Sasaki, S., R. Hashimoto, M. Kiuchi, K. Inoue, T. Ikumoto, R. Hirose, K. Chiba, Y. Hoshino, T. Okumoto, and T. Fujita. 1994. Fungal metabolites. Part 14. Novel potent immunosuppressants, mycestericins, produced by Myceria sterilia. J. Antibiot. 47:420.
11. Fujita, T., K. Inoue, S. Yamamoto, T. Ikumoto, S. Sasaki, R. Toyama, M. Yoneta, K. Chiba, Y. Hoshino, and T. Okumoto. 1994. Fungal metabolites. Part 12. Potent immunosuppressant, 14-deoxomyriocin, (2S, 3R, 4R)-(E)-2-amino-3,4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure-activity relationships of myriocin derivatives. J. Antibiot. 47:216.
12. Fujita, T., M. Yoneta, R. Hirose, S. Sasaki, K. Inoue, M. Kiuchi, S. Hirase, K. Adachi, M. Arita, and K. Chiba. 1995. Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activity. Bioorg. Med. Chem. Lett. 5:847.
13. Adachi, K., T. Kohara, N. Nakao, M. Arita, K. Chiba, T. Mishina, S. Sasaki, and T. Fujita. 1995. Design, synthesis, and structure activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720. Bioorg. Med. Chem. Lett. 5:853.
14. Fujita, T., R. Hirose, M. Yoneta, S. Sasaki, K. Inoue, M. Kiuchi, S. Hirase, K. Chiba, H. Sakamoto, and M. Arita. 1996. Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols. J. Med. Chem. 39:4451.
15. Chiba, K., Y. Hoshino, C. Suzuki, Y. Masubuchi, Y. Yanagawa, M. Ohtsuki, S. Sasaki, and T. Fujita. 1996. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rat. Transplant. Proc. 28:1056.
16. Hoshino, Y., C. Suzuki, M. Ohtsuki, Y. Masubuchi, Y. Amano, and K. Chiba. 1996. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allograft and synergistic effect in combination with cyclosporine A. Transplant. Proc. 28:1060.
17. Masubuchi, Y., T. Kawaguchi, M. Ohtsuki, C. Suzuki, Y. Amano, Y. Hoshino, and K. Chiba. 1996. FTY720, a novel immunosuppressant possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats. Transplant. Proc. 28:1064.
18. Kawaguchi, T., Y. Hoshino, F. Rahman, Y. Amano, H. Higashi, H. Kataoka, M. Ohtsuki, K. Teshima, K. Chiba, T. Kakefuda, and S. Suzuki. 1996. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplant. Proc. 28:1062.
19. Suzuki, S., S. Enosawa, T. Kakefuda, H. Amemiya, Y. Hoshino, and K. Chiba. 1996. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720. Transplant. Proc. 28:1375.
20. Suzuki, S., S. Enosawa, T. Kakefuda, T. Shinomiya, M. Amari, S. Naoe, Y. Hoshino, and K. Chiba. 1996, A novel immunosuppressant, FTY720, having a unique mechanism of action induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61:200.
21. Suzuki S., X.-K. Li, S. Enosawa, and T. Shinomiya. 1996. A new immunosuppressant. FTY720 induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 89:518.
22. Butcher E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
23. Arbones, M. L., D. C. Ord, K. Ley, H. Ratech, C. M. Curry, G. Otten, D. J. Capon, and T. F. Tedder. 1994. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1:247.
24. 4 integrins in lymphocyte homing to mucosal tissue in vivo. J. Immunol. 152:3282.
25. Imai, Y., L. A. Lasky, and S. D. Rosen,. 1993. Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature 361:555.
26. 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.
27. Gillis, S, M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
28. Chiba, K., T. Nishimura, and Y. Hashimoto. 1985. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF) III. Effect on cell proliferation and immune responses. J. Immunol. 134:3172.
29. Tanaka, T., T. Masuko, H. Yagita, T. Tamura, and Y. Hashimoto. 1989. Characterization of a CD3-like rat cell surface antigen recognized by a monoclonal antibody. J. Immunol. 142:2791.
30. Nicolls, M. R., G. G. Aversa, N. W. Pearce, A. Spinelli, M. F. Berger, K. E. Gurley, and B. M. Hall. 1993. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 55:459.
31. Woollett, G. R., A. N. Barclay, M. Puklavec, and A. F. Williams. 1985. Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes. Eur. J. Immunol. 15:168.
32. Jefferies, W. A., J. R. Green, and A. F. Williams. 1985. Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J. Exp. Med. 162:117.
33. Nagel, N. T., E. Kraus, M. H. Brown, G. Tiefenthaler, R. Mitnacht, A. F. Williams, and T. Hünig, 1992. Differential thymus dependence of rat CD8 isoform expression. Eur. J. Immunol. 22:2841.
34. Tamatani, T., F. Kitamura, K. Kuida, M. Shirao, M. Mochizuki, M. Suematsu, W. Schmid-Schönbein, K. Watanabe, S. Tsurufuji, and M. Miyasaka. 1993. Characterization of rat LECAM-1 (L-selectin) by the use of monoclonal antibodies and evidence for the presence of soluble LECAM-1 in rat sera. Eur. J. Immunol. 23:2181.
35. Issekutz, T. B. 1991. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. J. Immunol. 147:4178.
36. Tamatani, T., M. Kotani, and M. Miyasaka. 1991. Characterization of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Eur. J. Immunol. 21:627.
37. Westermann, J. G., S. Persin, J. Matyas, P. van der Meide, and R. Pabst. 1993. Interferon-gamma influences the migration of thoracic duct B and T lymphocyte subsets in vivo: random increase in disappearance from the blood and differential decrease in reappearance in the lymph. J. Immunol. 150:3843.
38. Martin, D. R., and R. G. Miller. 1989. In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J Exp. Med. 170:679.
39. Westermann, J., and R. Pabst. 1996. How organ-specific is the migration of "naïve" and "memory" T lymphocytes? Immunol. Today 17:278.
40. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30.
41. H. Blomgren and B. Anderson. 1971. Characteristics of the immunocompetent cells in the mouse thymus: cell changes during cortisone-induced atrophy and subsequent regeneration. Cell. Immunol. 1:545.
42. Bergar, J. 1980. Leukokinetic study: morphology of the bone marrow and blood after experimental induction of marrow hypoplasia by cyclophosphamide in laboratory rats. Folia Haematol. 107:862.
43. 2 integrins on naive peripheral lymphocytes. J. Exp. Med. 184:1343.
44. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79.
45. Stamper, H. B., Jr, and J. J. Woodruff. 1977. An in vitro model of lymphocyte homing. I. Characterization of the interaction between thoracic duct lymphocytes and specialized high endothelial venules of lymph nodes. J. Immunol. 119:772.
46. Steeber, D. A., N. E. Green, S. Sato, and T. F. Tedder. 1996. Lymphocyte-migration in L-selectin-deficient mice: altered subset migration and aging of the immune system. J. Immunol. 157:1096.
47. Steeber, D. A, N. E. Green, S. Sato, and T. F. Tedder. 1996. Humoral immune responses in L-selectin-deficient mice. J. Immunol. 157:4899.